MEDIUM CHAIN TRIGLYCERIDES (MCTs)
1,2,3-Propanetriol Trioctanoate, AC-1202, Acide Caprique, Acide Caproïque, Acide Caprylique, Acide Laurique, Capric Acid, Caproic Acid, Caprylic Acid, Caprylic Triglycerides, Laurate-rich MCTs, Lauric Acid, MCT, MCT's, MCTs, Medium-Chain Triacylglycerols, Medium-Chain Triglycerides, TCM, Triacylglycérols à Chaîne Moyenne, Tricaprylin, Triglycérides à Chaîne Moyenne, Triglycérides Capryliques, Triglicéridos de Cadena Media (TCMs), Trioctanoin.<br/><br/>
Overview InformationMedium chain triglycerides (MCTs) are partially man-made fats. The name refers to the way the carbon atoms are arranged in their chemical structure. MCTs are generally made by processing coconut and palm kernel oils in the laboratory. Usual dietary fats, by comparison, are long-chain triglycerides. People use MCTs as medicine.
Some people take MCTs by mouth along with usual medications for treating food absorption disorders including diarrhea, steatorrhea (fat indigestion), celiac disease, liver disease, and digestion problems due to partial surgical removal of the stomach (gastrectomy) or the intestine (short bowel syndrome).
MCTs are also taken by mouth for "milky urine" (chyluria) and a rare lung condition called chylothorax. Other uses include treatment of gallbladder disease, AIDS, cystic fibrosis, Alzheimer's disease, and seizures in children.
Athletes sometimes take MCTs by mouth for nutritional support during training, to increase exercise performance, for decreasing body fat and increasing lean muscle mass, and for weight loss.
MCTs are also sometimes taken by mouth to reduce levels of cholesterol and other fats in the blood called triglycerides. They might also be used for diabetes. In older people, MCTs are used to increase muscle mass and strength. They are also used for a rare disease called Waldmann disease.
MCTs are sometimes used as a source of fat in total parenteral nutrition (TPN). In TPN, all food is delivered intravenously (by IV). This type of feeding is necessary in people whose gastrointestinal (GI) tract is no longer working.
Intravenous MCTs are also given to prevent muscle breakdown in critically ill patients.
How does it work?MCTs are a fat source for patients who cannot tolerate other types of fats. Researchers also think that these fats produce chemicals in the body that might help fight Alzheimer's disease. These fats might also result in weight loss because the body uses them in a different way to other types of fats.
Uses & Effectiveness
Possibly Effective for
- Preventing muscle breakdown in critically ill patients, when given intravenously (by IV). MCTs can provide calories in critically ill patients, but don't seem to offer any advantages over normal dietary fats (long chain triglycerides).
- Certain types of seizures in children. Some research shows that taking MCTs by mouth can reduce some types of seizures such as akinetic, clonic, and petit mal.
- A rare disease called Waldmann disease. Following a low-fat, high-protein diet and supplementing with MCTs seems to reduce symptoms in patients with Waldmann disease.
Possibly Ineffective for
- Weight loss associated with AIDS. Some research shows that taking MCTs does not seem to be any more effective than taking multivitamins and minerals alone for prevention of weight loss associated with AIDS.
- Exercise performance. Most research shows that taking MCTs does not improve exercise performance. However, MCTs might help athletes exercise longer when taken with carbohydrates.
Insufficient Evidence for
- Muscle loss in the elderly. Early research shows that taking MCTs along with leucine and vitamin D increases the amount of muscle and improves strength in older people who have lost a lot of muscle mass.
- Alzheimer's disease. There is interest in using MCTs to treat Alzheimer's disease because MCTs might provide extra energy to the brain and might also protect the brain against damage from beta-amyloid protein plaques. These plaques are the structures that form in Alzheimer's disease and cause symptoms. Some research shows that a specific MCT product (AC-1202) does not significantly improve learning, memory and information processing (cognitive thinking) in people with mild to moderate Alzheimer's disease, except in people with a particular genetic make-up (change in the APOE4 gene). In the people with the APEO4 gene change, a single dose of the MCT product seems to improve cognitive thinking skills.
- Chylothorax (a rare lung disorder). Taking MCTs by mouth or intravenously (by IV) might prevent malnutrition and a weakened ability to fight infection in children and adults with chylothorax.
- High levels of fats in the blood (hypertriglyceridemia). Consuming an oil containing both medium- and long-chain fatty acids reduces levels of triglycerides in the blood in overweight patients. However, it might not be effective in people with high levels of these fats who are very overweight (obese) or normal-weight.
- Weight loss in obese or overweight individuals. Research shows that taking MCTs can decrease body weight, body fat, and waist and hip circumference by a small amount. At least 4 weeks of use is likely needed to see any benefit. Men, people of Asian descent, and people with the highest amount of body fat before treatment seem to benefit the most. However, for most people any benefit is only slight and might not be clinically meaningful.
- Decreasing body fat and increasing lean muscle.
- High levels of cholesterol in the blood.
- Improving the absorption of calcium and magnesium.
- Nutritional support of athletic training.
- Other conditions.
Side Effects & SafetyMCTs are LIKELY SAFE for most people when taken by mouth or given intravenously (by IV). They can cause diarrhea, vomiting, irritability, nausea, stomach discomfort, intestinal gas, essential fatty acid deficiency, and other side effects. Taking MCTs with food might reduce some side effects.
Special Precautions & Warnings:Pregnancy and breast-feeding: Not enough is known about the use of MCTs during pregnancy and breast-feeding. Stay on the safe side and avoid use.
Children: MCTs are POSSIBLY SAFE for most children when taken by mouth.
Diabetes: MCTs can cause certain chemicals called ketones to build up in the body. This can be a problem for people with diabetes. Avoid using MCTs if you have diabetes.
Liver problems: Because MCTs are processed primarily by the liver, they can cause serious problems in people with liver disease. Do not use MCTs if you have cirrhosis or other liver problems.
We currently have no information for MEDIUM CHAIN TRIGLYCERIDES (MCTs) Interactions.
The following doses have been studied in scientific research:
- For preventing muscle breakdown in critically ill patients: As a fat source for people who receive all their food intravenously (by IV): a fat mixture containing 50% MCTs and 50% long chain triglycerides (usual dietary fats) is commonly used in total parenteral nutrition (TPN) formulas.
- For improving seizure control: MCT oil is used as 60% of the calories eaten.
- Abe S, Ezaki O, Suzuki M. Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Increase Muscle Strength and Function in Frail Elderly Adults in a Randomized Controlled Trial. J Nutr. 2016 May;146(5):1017-26. View abstract.
- Babayan VK. Medium chain triglycerides and structured lipids. Lipids 1987;22:417-20. View abstract.
- Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 1982;36:950-62. View abstract.
- Ball MJ. Parenteral nutrition in the critically ill: use of a medium chain triglyceride emulsion. Intensive Care Med 1993;19:89-95. View abstract.
- Bhavsar N, St-Onge MP. The diverse nature of saturated fats and the case of medium-chain triglycerides: how one recommendation may not fit all. Curr Opin Clin Nutr Metab Care. 2016 Mar;19(2):81-7. View abstract.
- Brighenti F. Dietary fructans and serum triacylglycerols: a meta-analysis of randomized controlled trials. J Nutr. 2007 Nov;137(11 Suppl):2552S-2556S. doi: 10.1093/jn/137.11.2552S. View abstract.
- Calabrese C, Myer S, Munson S, et al. A cross-over study of the effect of a single oral feeding of medium chain triglyceride oil vs canola oil on post-ingestion plasma triglyceride levels in healthy men. Altern Med Rev 1999;4:23-8. View abstract.
- Christophe A, Matthys F, Verdonk G. Chylous-fluid triglycerides and lipoproteins in a patient with chylothorax put on a diet of butter or medium-chain triglyceride [proceeedings]. Arch Int Physiol Biochim 1980;88:B17-B19. View abstract.
- Clarke PJ, Ball MJ, Hands LJ, et al. Use of a lipid containing medium chain triglycerides in patients receiving TPN: a randomized prospective trial. Br J Surg 1987;74:701-4. View abstract.
- Clegg ME. Medium-chain triglycerides are advantageous in promoting weight loss although not beneficial to exercise performance. Int J Food Sci Nutr. 2010 Nov;61(7):653-79. View abstract.
- Coleman H, Quinn P, Clegg ME. Medium-chain triglycerides and conjugated linoleic acids in beverage form increase satiety and reduce food intake in humans. Nutr Res. 2016 Jun;36(6):526-33. View abstract.
- Desai AP, Guvenc BH, Carachi R. Evidence for medium chain triglycerides in the treatment of primary intestinal lymphangiectasia. Eur J Pediatr Surg. 2009 Aug;19(4):241-5. View abstract.
- Fernandez Alvarez JR, Kalache KD, Grauel EL. Management of spontaneous congenital chylothorax: oral medium-chain triglycerides versus total parenteral nutrition. Am J Perinatol 1999;16:415-20. View abstract.
- Gibert CL, Wheeler DA, Collins G, et al. Randomized, controlled trial of caloric supplements in HIV infection. J Acquir Immune Defic Syndr 1999;22:253-9. View abstract.
- Henderson ST, Vogel JL, Barr LJ, et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 2009;6:31. View abstract.
- Jain A, Mochi TB, Braganza SD, Agrawal S, Shetty BK, Pachiyappan B. Lipemia retinalis in an infant treated for retinopathy of prematurity. J AAPOS 2017;21(3):254-57. View abstract.
- Jalili F. Medium-chain triglycerides and total parenteral nutrition in the management of infants with congenital chylothorax. South Med J 1987;80:1290-3.. View abstract.
- Jensen GL, Mascioli EA, Meyer LP, et al. Dietary modification of chyle composition in chylothorax. Gastroenterology 1989;97:761-5. View abstract.
- McCarty MF, DiNicolantonio JJ. Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicity. Open Heart. 2016 Jul 27;3(2):e000467. View abstract.
- Mumme K, Stonehouse W. Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. J Acad Nutr Diet. 2015 Feb;115(2):249-63. View abstract.
- Nijveldt RJ, Tan AM, Prins HA, et al. Use of a mixture of medium-chain triglycerides and longchain triglycerides versus long-chain triglycerides in critically ill surgical patients: a randomized prospective double-blind study. Clin Nutr 1998;17:23-9. View abstract.
- Reger MA, Henderson ST, Hale C, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 2004;25:311-4. View abstract.
- Rego Costa AC, Rosado EL, Soares-Mota M. Influence of the dietary intake of medium chain triglycerides on body composition, energy expenditure and satiety: a systematic review. Nutr Hosp. 2012 Jan-Feb;27(1):103-8. View abstract.
- Ruppin DC, Middleton WR. Clinical use of medium chain triglycerides. Drugs 1980;20:216-24.
- Sills MA, Forsythe WI, Haidukewych D, et al. The medium chain triglyceride diet and intractable epilepsy. Arch Dis Child 1986;61:1168-72. View abstract.
- St-Onge MP, Jones PJ. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J Nutr 2002;132:329-32.. View abstract.
- St-Onge MP, Mayrsohn B, O'Keeffe M, Kissileff HR, Choudhury AR, Laferrère B. Impact of medium and long chain triglycerides consumption on appetite and food intake in overweight men. Eur J Clin Nutr. 2014 Oct;68(10):1134-40. View abstract.
- Trauner DA. Medium-chain triglyceride (MCT) diet in intractable seizure disorders. Neurology 1985;35:237-8. View abstract.
- Xue C, Liu Y, Wang J, Zhang R, Zhang Y, Zhang J, Zhang Y, Zheng Z, Yu X, Jing H, Nosaka N, Arai C, Kasai M, Aoyama T, Wu J. Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin Nutr. 2009 Jul;63(7):879-86. View abstract.
- Zhang Y, Liu Y, Wang J, Zhang R, Jing H, Yu X, Zhang Y, Xu Q, Zhang J, Zheng Z, Nosaka N, Arai C, Kasai M, Aoyama T, Wu J, Xue C. Medium- and long-chain triacylglycerols reduce body fat and blood triacylglycerols in hypertriacylglycerolemic, overweight but not obese, Chinese individuals. Lipids. 2010 Jun;45(6):501-10. View abstract.
Have you ever purchased MEDIUM CHAIN TRIGLYCERIDES (MCTs)?
Did you or will you purchase this product in-store or online?
Where did you or where do you plan to purchase this product?
Where did you or where do you plan to purchase this product?
What factors influenced or will influence your purchase? (check all that apply)
Where did you or where do you plan to purchase this product?
Do you buy vitamins online or instore?
What factors are most important to you? (check all that apply)